Amy Everitt, PharmD, MS, RPh

Amy Everitt, PharmD, MS, RPh, has a diverse and extensive work experience in the pharmaceutical industry. Amy currently works as the Director of Scientific Communications (Rare Neurological Sleep Disorders) at Avadel Pharmaceuticals plc. Previously, they held positions at Tris Pharma as the Director of Field Medical Strategy (CNS Disorders) and as a Senior Medical Science Liaison (Neuroscience). Prior to this, Amy worked at Sunovion Pharmaceuticals as the Director of Medical Science Liaison (Psychiatry) and at Otsuka Pharmaceutical Companies as a Neuroscience Medical Science Liaison.

Amy also gained experience at Bristol-Myers Squibb, where they served as the Global Publications Operations Lead (Neuroscience) and in Medical Information and Medical Strategy (Neuroscience) roles. Before entering the pharmaceutical industry, Amy worked as an Adjunct Faculty at Rutgers University, where they co-coordinated and taught pharmacy courses and served in various leadership roles. Amy began their career as a Clinical Psychiatric Pharmacist Intern at South Florida State Hospital and worked as a Certified Pharmacy Technician in various community pharmacies.

Overall, Amy has demonstrated expertise in scientific communications, field medical strategy, medical science liaison roles, publications operations, medical information, pharmacology, and pharmacy education.

Amy Everitt, PharmD, MS, RPh holds a Doctor of Pharmacy (Pharm.D.) degree from Nova Southeastern University. Amy also has a Master of Science (M.S.) degree in Clinical Psychopharmacology from Fairleigh Dickinson University. Amy completed their undergraduate studies in Pre-Pharmacy and Dance at the University of Houston and the University of Nevada-Las Vegas. In addition to their degrees, they have obtained the Global Medical Neuroscience Fellowship (2-year) from Rutgers University in 2012 and is a Registered Pharmacist in the State of New Jersey since February 2015.